Sr. Director, Market Access – Payer Value & Access Strategies
AbbottSalary not specified
Full Time
Senior (5 to 8 years), Expert & Leadership (9+ years)
Director, ICON MAx, International Market Access at Bristol-Myers Squibb
Princeton, New Jersey, United States
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries
Requirements
- Market Access experience from within a Country/Affiliate, with deep expertise in Latin America
- Ideally, knowledge of Middle East & Africa market access
- Broad knowledge across Oncology, Hematology, Neurology, Cardiology, and Immunology
- Strong skills in global payment systems, pricing, health economics, evidence generation, and real-world data
- Experience leading cross-functional teams
- Experience developing impactful communication tools for payers, regulators, advocacy groups, and industry stakeholders
- Exceptional matrix management skills
- Ability to oversee multiple projects
- Commitment to accountability, innovation, and knowledge-sharing
Responsibilities
- Represent Market Access (Global, Regional and Countries) within the LatAm-LT meetings
- Disseminate global market access strategies for BMS’s in-line and pipeline assets in ICON, integrating these strategies into broader regional commercial plans in close collaboration with cross-functional local and regional leads
- Partner with Global Market Access and Pricing Leads to ensure registrational trial designs address future ICON market access requirements
- Serve as a strategic extension of the Head of ICON MAx, facilitating seamless communication and information flow across in-country MAx teams
- Drive priority market access projects and initiatives, collaborating with Global Market Access, HEOR, Pricing, and GP&GA to ensure successful execution
- Provide strategic analysis and recommendations to support decision-making
- Drive market access and pricing strategies across geographies in MEA, LatAm, and Brazil
- Ensure alignment between local Intercon Market Access teams and Global Market Access, supporting the entire BMS portfolio and pipeline
- Collaborate with global and local MAx leaders, Global Policy, Medical, and Commercial teams to communicate the value of BMS therapies to government authorities, Private Payers, and HTA organizations
- Develop innovative access, pricing, and contracting solutions with Local and Regional teams to secure patient access and manage New Product Portfolio (NPP) workstreams for pipeline assets
- Maximize pipeline value through strategic planning and evidence generation, integrating regional market access perspectives
- Deliver on the BMS growth portfolio and execute near-term launches by accelerating strategic decision-making
- Advance BMS and the MAx culture and build a community of practice by fostering a connected access team
Skills
Market Access
Pricing Strategies
HTA
Contracting
Global Policy
Commercial Strategy
Latin America
Middle East
Africa
Patient Access
Bristol-Myers Squibb
Develops and delivers biopharmaceutical medicines
About Bristol-Myers Squibb
Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.
New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees